COL9A3
protein-codingcollagen type IX alpha 3 chain, the group of Collagen proteoglycans|Collagens
Gene summary
This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~24.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019354
Submitter: ClinGen
*COL9A3* was reported in relation to autosomal recessive Stickler syndrome in 2014 (Faletra et al., 24273071). Of note, this gene has also been implicated in multiple epiphyseal dysplasia, susceptibility to intervertebral disc disease, and non-syndromic hearing loss. These have been or will be assessed separately. At least eight unique nonsense variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least seven probands in five publications (PMID: 24273071, 30450842,31090205,33570243, 35241111). This gene-disease association is supported by expression studies and animal models(PMIDs: 1844825,15802199, 20686772). In summary, there is definitive evidence to support this gene-disease relationship. This gene-disease pair was originally evaluated by the Hearing Loss Working group on September 18th 2019 (SOP Version 7). It was reevaluated on December 21st 2022. As a result of this reevaluation, the classification did change from moderate to definitive due and new case level evidence was reviewed and added (SOP Version 9)
Inheritance Pattern: AD
Disease ID:MONDO:0010964
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0031047
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0010964
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0016647
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0010964
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0015627
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019354
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0031047
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0010964
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0031047
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0019354
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Ophthalmologic
Intervention: Audiologic/Otolaryngologic; Ophthalmologic
Rationale: Though the condition may be recognizable, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Avoidance of risk factors related to ocular manifestations (eg, contact sports) is indicated
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to COL9A3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001853.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 21 | 301 | 1 | 323 | ||
| missense | 1 | 650 | 54 | 705 | ||
| nonsense | 10 | 7 | 5 | 22 | ||
| start loss | 2 | 1 | 3 | |||
| frameshift | 17 | 16 | 10 | 43 | ||
| splice donor/acceptor (+/-2bp) | 4 | 9 | 35 | 48 | ||
| Total | 31 | 35 | 722 | 355 | 1 | 1144 |
Highest pathogenic variant AF is 0.000014893622
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001844.3 | 32 | MANE Select | |
| Ensembl | ENSP00000496793.1 | 32 | MANE Select | |
| Ensembl | ENSP00000394280.1 | 12 | Standard | |
| Ensembl | ENSP00000564791.1 | 31 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- ECM-receptor interaction - Homo sapiens (human)
- Focal adhesion - Homo sapiens (human)
- Protein digestion and absorption - Homo sapiens (human)
- Human papillomavirus infection - Homo sapiens (human)
Biological Process
- male gonad development
- female gonad development
- extracellular matrix organization
Molecular Function
- extracellular matrix structural constituent
- extracellular matrix structural constituent conferring tensile strength
Cellular Component
- extracellular region
- collagen type IX trimer
- extracellular space
- endoplasmic reticulum lumen
- extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000343916
- Coding exons
- 32
- Length
- 24916
- Individuals with no LoFs
- 125688
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 60
- Defined
- 125748
- p
- 0.000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.382 | 471 | 448 | 1.05 | 0.0000293 | 4119 |
| Missense (PolyPhen) | 186 | 192.84 | 0.96454 | 1756 | ||
| Synonymous | -2.33 | 231 | 190 | 1.21 | 0.0000144 | 1544 |
| Loss of Function | 3.00 | 27 | 49.9 | 0.541 | 0.00000303 | 525 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00032 | 0.00031 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00025 | 0.00025 | rare |
| South Asian | 0.00036 | 0.00036 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Structural component of hyaline cartilage and vitreous of the eye.;
- Disease
- DISEASE: Multiple epiphyseal dysplasia 3 (EDM3) [MIM:600969]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:10090888, ECO:0000269|PubMed:25381065}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:11308397, ECO:0000269|PubMed:25381065}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Susceptibility to intervertebral disk disease is conferred by variant p.Arg103Trp (PubMed:11308397). {ECO:0000269|PubMed:11308397}.;
Intolerance Scores
- LoFtool
- 0.0916
- RVIS EVS
- 0.61
- RVIS percentile EVS
- 82.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.808
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |